You can read the full August 23 print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
The figures are jaw-dropping. E-commerce sales were rising steadily pre-COVID; however, they accelerated dramatically as the pandemic forced lockdowns and store closures across the United States. In fact, consumers went online for extra purchases to the tune of an additional $105 billion revenue last year, resulting in $790 billion total sales, according to Digital Commerce
Over the past year, we’ve been inundated with analyses, blogs, tweets and lectures trying to make sense of the “new normal” caused by the disruptions of the COVID-19 pandemic. For some, the new normal means masks in all public settings. For others, it means lasting concerns about physical contact. In retail, we’ve heard the new
Even as the swift spread of the Delta variant in the U.S. and other countries around the world brings renewed urgency to the battle against COVID-19, another, arguably graver, crisis continues to unfold. Climate change and its ability to wreak havoc on the natural environment is rapidly intensifying, a development that promises a time of
COVID-19 invoked a collective emphasis on health and wellness among Americans, causing shoppers to pay more attention to the products that they’re putting into and on their bodies. The majority of shoppers consider health and wellness issues and needs when shopping, whether they’re looking for foods that fit new lifestyles, shopping for nontoxic products, or
